Skip to content

Rhonda Farnum, SVP, Comm & Medical Affairs at Theravance Biopharma, sold TBPH on Sep 15, 2026

Data as of Oct 16

▼ SELL$113K6,657 shares at $17.03Rhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.
Watch TBPH
Traded
Sep 15, 2026
Disclosed
Sep 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Rhonda Farnum, SVP, Comm & Medical Affairs at Theravance Biopharma, sold TBPH on Sep 15, 2026TRADEDDISCLOSED
TBPHSimilar stocks (XLV — its sector index fund), rebased to TBPH's price on the disclosure day
TBPH since disclosure
−0.1%
after the sale
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund

Change in closing price from Sep 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade
  2. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade

See every trade on TBPH →